Mechanisms of alveolar epithelial apoptosis during acute lung injury
急性肺损伤时肺泡上皮细胞凋亡的机制
基本信息
- 批准号:8376675
- 负责人:
- 金额:$ 35.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至
- 项目状态:未结题
- 来源:
- 关键词:Acute Lung InjuryAddressAdult Respiratory Distress SyndromeAlveolarApoptosisApoptoticBiologicalBlood capillariesCell DeathCell Differentiation processCellsClinicalDepositionDevelopmentDiffuseEpithelialEpithelial CellsEpitheliumExtracellular MatrixFamily memberFibroblastsFibrosisFunctional disorderGenesGeneticGrantHourIn VitroInflammatoryInjuryLiquid substanceLungMesenchymalMolecularMusMyofibroblastOutcomePathway interactionsPatientsProcessProteinsPulmonary FibrosisReportingResearchRoleSignal PathwaySupportive careUnited StatesVentilatoranimal databasecapillaryhuman TGFB1 proteinhuman dataimprovedin vivoinjury and repairlung injurymortalitymouse modelnovel therapeuticspreventrepairedtissue repair
项目摘要
Approximately 150,000 people in the United States develop acute lung injury (All) and the acute respiratory
distress syndrome (ARDS) annually (1). Despite research driven advances in therapy, ~40% of these
patients will die. All and ARDS often manifest as a part of a systemic inflammatory process resulting in the
development of diffuse alveolar epithelial damage and capillary injury with the exudation of protein rich fluid
into the alveolar space. As part of the alveolar-capillary repair ALI/ARDS patients develop a
fibroproliferative process that is characterized by the proliferation of mesenchymal cells, differentiation of
mesenchymal cells into myofibroblasts and deposition of extracellular matrix. The molecular and cellular
mechanisms underlying fibroproliferation during ALI and ARDS are not fully understood. Transforming
growth factor-beta 1 (TGF-31) is integral for fibroblast activation and tissue repair. Multiple reports over the
last 10 years have described a role for early fibroblast activation in determining the outcome of patients with
the ARDS. How TGF-31 induces lung fibrosis following epithelial injury is not fully understood. To date
there is no genetic evidence to indicate whether epithelial apoptosis is sufficient and required for the initiation
of lung injury followed by pulmonary fibrosis. We propose that TGF-31 induces lung injury and fibrosis by
activating the intrinsic apoptotic pathway in alveolar epithelial cells. The intrinsic apoptotic pathway is
regulated by the Bcl-2 family members. In support of our hypothesis, we have reported that loss of the proapoptotic
Bcl-2 family member Bid prevents TGF-31 induced fibrosis in mice. The purpose of this grant is to
elucidate the mechanisms by which TGF-31 induces Bid dependent epithelial cell death resulting in lung
injury and fibrosis. The current proposal will address these questions utilizing genetics in mouse models of
lung injury and fibrosis.
在美国大约有150,000人发生急性肺损伤(All)和急性呼吸道损伤(ALL)。
急性呼吸窘迫综合征(ARDS)每年(1)。尽管研究推动了治疗的进步,但其中约40%的人
病人会死。ALL和ARDS通常表现为全身性炎症过程的一部分,
弥漫性肺泡上皮损伤和毛细血管损伤的发展,伴有富含蛋白质的液体渗出
进入肺泡腔作为肺泡-毛细血管修复的一部分,ALI/ARDS患者发展为
纤维增殖过程的特征在于间充质细胞的增殖、间充质细胞的分化、间充质细胞的分化、间充质细胞的增殖、间充质细胞的分化、间充质细胞的增殖、间充质细胞的分化、间充质细胞的增殖、间充质细胞的分化、间充质细胞的增殖、间充质细胞的增殖、间充质细胞的分化、间充质细胞的增殖、间充质细胞的分化、间充质细胞的增殖、间充质细胞的分化、间充质细胞的增殖、间充质细胞的分化、间充质细胞的增殖和间充质细胞的增殖。
间充质细胞转化成肌成纤维细胞和细胞外基质沉积。分子和细胞
ALI和ARDS期间纤维增生的潜在机制尚未完全了解。转化
生长因子-β 1(TGF-β 1)是成纤维细胞活化和组织修复所必需的。多份报告显示,
过去10年来,已经描述了早期成纤维细胞活化在确定患有糖尿病的患者的结果中的作用。
ARDS。TGF-31如何诱导上皮损伤后的肺纤维化尚不完全清楚。迄今
没有遗传学证据表明上皮细胞凋亡是否是足够的,并且是启动所需的,
肺损伤后肺纤维化我们认为TGF-31通过以下途径诱导肺损伤和纤维化:
激活肺泡上皮细胞的内在凋亡途径。内源性凋亡途径是
由Bcl-2家族成员调控。为了支持我们的假设,我们已经报道了前凋亡蛋白的丢失,
Bcl-2家族成员Bid预防TGF-31诱导的小鼠纤维化。该补助金的目的是
阐明TGF-31诱导Bid依赖性上皮细胞死亡的机制,
损伤和纤维化。目前的建议将利用遗传学在小鼠模型中解决这些问题,
肺损伤和纤维化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAVDEEP S CHANDEL其他文献
NAVDEEP S CHANDEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAVDEEP S CHANDEL', 18)}}的其他基金
Project 2: Metabolic regulation of host response and repair mechanisms to influenza A viral pneumonia
项目2:甲型流感病毒性肺炎宿主反应及修复机制的代谢调节
- 批准号:
10269675 - 财政年份:2021
- 资助金额:
$ 35.45万 - 项目类别:
Project 2: Metabolic regulation of host response and repair mechanisms to influenza A viral pneumonia
项目2:甲型流感病毒性肺炎宿主反应及修复机制的代谢调节
- 批准号:
10696964 - 财政年份:2021
- 资助金额:
$ 35.45万 - 项目类别:
Mitochondrial metabolism and ROS regulate cancer
线粒体代谢和 ROS 调节癌症
- 批准号:
9920105 - 财政年份:2016
- 资助金额:
$ 35.45万 - 项目类别:
Mitochondrial metabolism and ROS regulate cancer
线粒体代谢和 ROS 调节癌症
- 批准号:
10414889 - 财政年份:2016
- 资助金额:
$ 35.45万 - 项目类别:
Mitochondrial metabolism and ROS regulate cancer
线粒体代谢和 ROS 调节癌症
- 批准号:
9211296 - 财政年份:2016
- 资助金额:
$ 35.45万 - 项目类别:
Mitochondrial metabolism and ROS regulate cancer
线粒体代谢和 ROS 调节癌症
- 批准号:
10170279 - 财政年份:2016
- 资助金额:
$ 35.45万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 35.45万 - 项目类别:
Research Grant














{{item.name}}会员




